WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Reaches New 12-Month High – Here’s Why

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) hit a new 52-week high on Monday . The stock traded as high as $13.6950 and last traded at $13.4450, with a volume of 1847 shares changing hands. The stock had previously closed at $12.79.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, WuXi Biologics (Cayman) has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Up 5.2%

The firm’s fifty day simple moving average is $11.44 and its 200 day simple moving average is $9.62.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.